Analyst downgrades typically lead to a negative short-term reaction in the stock market as they suggest a less favorable outlook on the company's future performance. Given the downgrade from Buy to Neutral, it's likely that investor sentiment around AVITA Medical may become more cautious, potentially leading to a decrease in stock price in the short term.